{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981471477906304.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1093/ndt/gfq665"}},{"identifier":{"@type":"URI","@value":"http://academic.oup.com/ndt/article-pdf/26/2/414/5353981/gfq665.pdf"}}],"dc:title":[{"@value":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380290617559930627","@type":"Researcher","foaf:name":[{"@value":"A. McGrogan"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471477906304","@type":"Researcher","foaf:name":[{"@value":"C. F. M. Franssen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471477906306","@type":"Researcher","foaf:name":[{"@value":"C. S. de Vries"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09310509"},{"@type":"EISSN","@value":"14602385"}],"prism:publicationName":[{"@value":"Nephrology Dialysis Transplantation"}],"dc:publisher":[{"@value":"Oxford University Press (OUP)"}],"prism:publicationDate":"2010-11-10","prism:volume":"26","prism:number":"2","prism:startingPage":"414","prism:endingPage":"430"},"reviewed":"false","url":[{"@id":"http://academic.oup.com/ndt/article-pdf/26/2/414/5353981/gfq665.pdf"}],"createdAt":"2010-11-11","modifiedAt":"2021-11-13","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050582186290291584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Kidney outcomes associated with haematuria and proteinuria trajectories among patients with IgA nephropathy in real-world clinical practice: The Japan Chronic Kidney Disease Database"},{"@value":"Kidney outcomes associated with haematuria and proteinuria trajectories among patients with <scp>IgA</scp> nephropathy in real‐world clinical practice: The Japan Chronic Kidney Disease Database"}]},{"@id":"https://cir.nii.ac.jp/crid/1050852252677506560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282229307392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692584897152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286992073466496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617828985856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643858018688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Phenotypic Difference of IgA Nephropathy and its Race/Gender-dependent Molecular Mechanisms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905150957696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rigorous multiple statistical test unveils combinations of preceding diseases at risk for the development of adult nephrotic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306906091345024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Machine-learning-based identification of patients with IgA nephropathy using a computerized medical billing database"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166012359296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232420202240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659411850880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659716218496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper‐IgA mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814746143616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814752401536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814755863552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podocyte number and glomerulosclerosis indices are associated with the response to therapy for primary focal segmental glomerulosclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816801989248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869854349531648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New Insights and Future Perspectives of APRIL in IgA Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855113700608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characterization of FAM114A1: a novel podocyte cytoskeleton-associated protein upregulated in glomerular injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1390025794717906688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two-year Follow-up of IgA Nephropathy Patients Who Developed Gross Hematuria Following COVID-19 Vaccination: A Case Series and Literature Review"}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942148268160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome : the Japan Nephrotic Syndrome Cohort Study (JNSCS)"}]},{"@id":"https://cir.nii.ac.jp/crid/2050307417124992384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The revised version 2018 of the nationwide web-based registry system for kidney diseases in Japan : Japan Renal Biopsy Registry and Japan Kidney Disease Registry"}]},{"@id":"https://cir.nii.ac.jp/crid/2051433317038755712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Deep learning analysis of clinical course of primary nephrotic syndrome : Japan Nephrotic Syndrome Cohort Study (JNSCS)"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/ndt/gfq665"},{"@type":"CROSSREF","@value":"10.1089/mab.2018.0041_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.34067/kid.0002972021_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.3390/biomedicines10123027_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5548-25_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfv221_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1038/s41598-020-77736-1_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1016/j.autrev.2020.102671_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1111/nep.14250_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1016/j.compbiomed.2025.110360_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0312915_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1016/j.kint.2019.01.031_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1007/s10157-022-02256-3_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.3390/jcm11113173_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1096/fj.201801748r_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1007/s10157-020-01864-1_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1007/s10157-020-01932-6_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.3389/fimmu.2023.1165394_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1038/s41598-023-41909-5_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.3389/fmed.2024.1343161_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1093/ckj/sfad199_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.3390/ijms251910340_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1152/ajprenal.00203.2024_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"},{"@type":"CROSSREF","@value":"10.1016/j.kint.2017.10.019_references_DOI_L84sdvIl8krSD2uzefHWEvKvQTW"}]}